A Review of TIP #63: Medications for Opioid Use Disorder
Date & Time
Tuesday, April 3, 2018, 3:45 PM - 5:00 PM
Moderator: Stephanie McCladdie, MPA, Regional Administrator, Region 4, Substance Abuse and Mental Health Services Administration
This session will provide an overview of the Substance Abuse and Mental Health Services Administration's Treatment Improvement Protocol (TIP) #63 on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder (OUD) — methadone, naltrexone and buprenorphine — and the other strategies and services needed to support recovery. An expert panel developed the TIP’s content based on a review of the literature and on their extensive experience in the field of addiction treatment. The five sections of the TIP include (1) laying the groundwork for understanding treatment concepts; (2) guidance on OUD screening, assessment, treatment and referral; (3) information and tools for healthcare professionals who prescribe, administer or dispense OUD medications or treat other illnesses in patients who take these medications; (4) ways that addiction treatment counselors can collaborate with healthcare professionals to support client-centered, trauma-informed OUD treatment and recovery; and (5) a glossary and list of audience-segmented resources. TIP #63 is a key resource for healthcare and addiction professionals, policymakers, administrators, peer support specialists, patients and families.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Describe the different forms of medications to treat OUD and the evidence behind them.
- Identify engagement strategies that can be used in various treatment settings.
- Outline strategies for clear communication with prescribers and creation of supportive environments for clients who take OUD medication.